We are live on
!
Find out more
DMKJ
David M. Knott Jr Portfolio holdings
AUM
$168M
1-Year Est. Return
60.36%
This Fund
S&P 500
This Quarter
Est. Return
+8.55%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$290K
(-0.11%)
Cap. Flow
-$14M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
74.48%
Holding
143
New
12
Increased
13
Reduced
10
Closed
30
Top Buys
| 1 |
Panagram BBB-B CLO ETF
CLOZ
|
+$15.7M |
| 2 |
Invesco AAA CLO Floating Rate Note ETF
ICLO
|
+$5.87M |
| 3 |
Janus Henderson AAA CLO ETF
JAAA
|
+$3.12M |
| 4 |
Sanofi
SNY
|
+$2.3M |
| 5 |
Panagram AAA CLO ETF
CLOX
|
+$1.96M |
Top Sells
| 1 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
+$10.2M |
| 2 |
MITAW
Coliseum Acquisition Corp. Warrant
MITAW
|
+$5.69M |
| 3 |
FBRT
Franklin BSP Realty Trust
FBRT
|
+$4.34M |
| 4 |
Calumet Specialty Products
CLMT
|
+$4.07M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$3.82M |
Sector Composition
| 1 | Materials | 30.32% |
| 2 | Healthcare | 27.8% |
| 3 | Financials | 10.28% |
| 4 | Industrials | 8.49% |
| 5 | Communication Services | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Calumet Specialty Products
CLMT
$3.6B
| $77.3M | 29.54% |
4,325,000
-251,000
| -5% | -$4.07M |
|
2
Apollo Global Management
APO
$70.3B
| $21M | 8.01% |
225,000
| – | – |
|
3
FTAI Aviation
FTAI
$20.5B
| $19.7M | 7.54% |
425,000
| – | – |
|
|
4
Panagram BBB-B CLO ETF
CLOZ
$764M
| $19M | 7.26% |
719,368
+598,336
| +494% | +$15.7M |
|
5
Alphabet (Google) Class C
GOOG
$4.42T
| $15.8M | 6.04% |
112,220
| – | – |
|
6
DocGo
DCGO
$62.6M
| $10.8M | 4.11% |
1,925,000
| – | – |
|
7
Ardelyx
ARDX
$1.27B
| $8.56M | 3.27% |
1,380,000
-120,000
| -8% | -$538K |
|
8
Ligand Pharmaceuticals
LGND
$5.92B
| $8.21M | 3.14% |
115,000
| – | – |
|
|
9
Invesco AAA CLO Floating Rate Note ETF
ICLO
$509M
| $7.85M | 3% |
307,019
+229,642
| +297% | +$5.87M |
|
10
OmniAb
OABI
$297M
| $6.7M | 2.56% |
1,086,505
| – | – |
|
11
Viking Therapeutics
VKTX
$4.21B
| $5.04M | 1.93% |
270,822
+85,267
| +46% | +$1.12M |
|
|
12
Janus Henderson AAA CLO ETF
JAAA
$29B
| $4.71M | 1.8% |
93,647
+62,215
| +198% | +$3.12M |
|
13
JPMorgan Chase
JPM
$912B
| $3.57M | 1.36% |
20,985
| – | – |
|
|
AVDL
14
DELISTED
Avadel Pharmaceuticals
AVDL
| $3.56M | 1.36% |
251,850
+30,000
| +14% | +$352K |
|
15
Madrigal Pharmaceuticals
MDGL
$12.4B
| $3.42M | 1.31% |
14,800
-200
| -1% | -$35K |
|
16
Pfizer
PFE
$143B
| $2.81M | 1.07% |
97,537
| – | – |
|
17
CSX Corp
CSX
$94.2B
| $2.43M | 0.93% |
70,000
| – | – |
|
18
GSK
GSK
$106B
| $2.41M | 0.92% |
65,000
| – | – |
|
|
INZY
19
DELISTED
Inozyme Pharma
INZY
| $2.4M | 0.92% |
564,549
+110,541
| +24% | +$393K |
|
|
20
Panagram AAA CLO ETF
CLOX
$309M
| $2.35M | 0.9% |
92,956
+77,316
| +494% | +$1.96M |
|
|
21
Sanofi
SNY
$106B
| $2.34M | 0.89% |
+47,000
| New | +$2.3M |
|
22
Catalyst Pharmaceutical
CPRX
| $2.11M | 0.81% |
+125,450
| New | +$1.71M |
|
23
Travere Therapeutics
TVTX
$5.06B
| $1.99M | 0.76% |
221,005
+120,688
| +120% | +$879K |
|
24
Coherus Oncology
CHRS
$214M
| $1.75M | 0.67% |
526,312
-103,688
| -16% | -$278K |
|
25
Cenovus Energy
CVE
$51B
| $1.58M | 0.6% |
95,000
| – | – |
|
Similar funds
DI
WFS
CCG
7CM
TT
MAG
PFA
CW